BioFlyte has filed a notice of an exempt offering of securities to raise $7,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, BioFlyte is raising $7,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Todd Sickles played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About BioFlyte
We are commercializing a revolutionary new class of fieldable aerosol mass spectrometers and complementary products for protection from biological and low-volatility chemical threats. Our products are expandable and do not rely on expensive reagents and consumables. Real-time: In just 5 minutes, we detect bacteria, spores, viruses, bio-toxins, fentanyl, and other airborne hazards. Accurate: We use real-world validation data from transportation hubs, public venues, and commercial buildings for continuous improvement. Reliable: Robotic sample handling, tracking, and storage enable autonomous operation for months at a time.
To learn more about BioFlyte, visit http://www.bioflyte.com/
Contact:
Todd Sickles, Chief Executive Officer
703-946-6233
https://www.linkedin.com/in/todd-sickles-56b8227/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.